Engin ÇETİN, İsmail DALDAL, Ali EREN, SAADET ÖZEN AKARCA DİZAKAR, SUNA ÖMEROĞLU, MUHAMMET BORA UZUNER, HAKAN HAMDİ ÇELİK, Hasan Hüseyin SAYGILI, BENAT KOÇKAR, ALPASLAN ŞENKÖYLÜ

Epidermal growth factor enhances spinal fusion: Posterolateral lumbar fusion model on rats

Objective: The aim of this study was to investigate the effects of human recombinant epidermal growth factor (EGF) on posterolateral lumbar fusion in a rat model. Methods: 36 male Sprague Dawley rats underwent posterolateral fusion at L4-5 level. They were randomly assigned to 3 groups: 1- Sham control group where no local augmentation was made, 2- Local Hydoxyapatite b-tricalcium phosphate (HA/b-TCP) augmentation group and 3- Local HA/b-TCP þ EGF augmentation group. Rats were euthanized at 8 weeks post-surgery. 6 rats from each group were selected for manual palpation examination, micro-computed tomography analysis and histologic analysis; and the rest was used for biomechanical analysis. Results: Based on manual palpation, there was no fusion in the sham control group. Fusion rate was 33.3% in the HA/b-TCP group and 66.7% in the HA/b-TCP þ EGF group (p ¼ 0.085). Micro-CT results revealed that new bone formation was higher in the HA/b-TCP þ EGF group (BV/TV: 40% vs. 65%) (p ¼ 0.004). Histologically newly formed bone tissue was more pronounced in the EGF group and compacted and bridging bone spicules were observed. The median maximum bending moment values were 0.51 Nmm (0.42e0.59), 0.73 Nmm (0.49e0.88) and 0.91 Nmm (0.66e1.03) in the sham control, HA/ b-TCP and HA/b-TCP þ EGF groups, respectively (p ¼ 0.013). The median stiffness values were 1.69 N/mm (1.12e2.18), 1.68 N/mm (1.13e2.74) and 3.10 N/mm (1.66e4.40) as in the previous order (p ¼ 0.087). Conclusion: This study demonstrates that EGF enhances posterolateral lumbar fusion in the rat model. EGF in combination with ceramic grafts increased the fusion rates. Our findings may provide insights to further studies, investigating EGF's clinical usage as an alternative fusion enhancer.

___

Geisinger JR, Park DK. Allograft bone: uses in spinal surgery. Semin Spine Surg. 2016 Dec;28(4):190e195.

Kadam A, Millhouse PW, Kepler CK, et al. Bone substitutes and expanders in spine surgery: a review of their fusion efficacies. Int J Spine Surg. 2016 Sep 22;10:33.

Grabowski G, Cornett CA. Bone graft and bone graft substitutes in spine surgery: current concepts and controversies. J Am Acad Orthop Surg. 2013 Jan;21(1):51e60.

Duarte RM, Varanda P, Reis RL, Duarte ARC, Correia-Pinto J. Biomaterials and bioactive agents in spinal fusion. Tissue Eng Part B Rev. 2017 Dec;23(6): 540e551.

Martí-Carvajal AJ, Gluud C, Nicola S, et al. Growth factors for treating diabetic foot ulcers. Cochrane Database Syst Rev. 2015 Oct;28(10):CD008548.

Chim SM, Tickner J, Chow ST, et al. Angiogenic factors in bone local environment. Cytokine Growth Factor Rev. 2013 Jun;24(3):297e310.

Platt MO, Roman AJ, Wells A, Lauffenburger DA, Griffith LG. Sustained epidermal growth factor receptor levels and activation by tethered ligand binding enhances osteogenic differentiation of multi-potent marrow stromal cells. J Cell Physiol. 2009 Nov;221(2):306e317.

Wang X, Chen W, Liu Q, et al. Function and mechanism of mesoporous bioactive glass adsorbed epidermal growth factor for accelerating bone tissue regeneration. Biomed Mater. 2017 Apr;12(2):025020.

Marquez L, De Abreu FAM, Ferreira CL, Alves GD, Miziara MN, Alves JB. Enhanced bone healing of rat tooth sockets after administration of epidermal growth factor (EGF) carried by liposome. Injury. 2013 Apr;44(4):558e564.

Lee JH, Jang S-J, Baek H-R, Lee KM, Chang B-S, Lee C-K. Synergistic induction of early stage of bone formation by combination of recombinant human bone morphogenetic protein-2 and epidermal growth factor. J Tissue Eng Regen Med. 2015 Apr;9(4):447e459.

Morimoto T, Kaito T, Matsuo Y, et al. The bone morphogenetic protein-2/7 heterodimer is a stronger inducer of bone regeneration than the individual homodimers in a rat spinal fusion model. Spine J. 2015 Jun;15(6): 1379e1390.

Emery SE, Brazinski MS, Koka A, Bensusan JS, Stevenson S. The biological and biomechanical effects of irradiation on anterior spinal bone grafts in a canine model. J Bone Joint Surg Am. 1994 Apr;76(4):540e548.

Carragee EJ, Hurwitz EL, Weiner BK. A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned. Spine J. 2011 Jun;11(6):471e491.

Cahill KS, Chi JH, Day A, Claus EB. Prevalence, complications, and hospital charges associated with use of bone-morphogenetic proteins in spinal fusion procedures. JAMA. 2009 Jul;302(1):58e66.

Buser Z, Drapeau S, Stappenbeck F, Pereira RC, Parhami F, Wang JC. Effect of Oxy133, an osteogenic oxysterol, on new bone formation in rat two-level posterolateral fusion model. Eur Spine J. 2017 Nov;26(11):2763e2772.

Grauer JN, Bomback DA, Lugo R, Troiano NW, Patel TC, Friedlaender GE. Posterolateral lumbar fusions in athymic rats: characteristization of a model. Spine J. 2004 May-Jun;4(3):281e286.

Chan SY, Wong RW. Expression of epidermal growth factor in transgenic mice causes growth retardation. J Biol Chem. 2000 Dec;275(49):38693e38698.

Marie PJ, Hott M, Perheentupa J. Effects of epidermal growth factor on bone formation and resorption in vivo. Am J Physiol. 1990 Feb;258(2 Pt 1): E275eE281.

Alves JB, Ferreira CL, Martins AF, et al. Local delivery of EGF-liposome mediated bone modeling in orthodontic tooth movement by increasing RANKL expression. Life Sci. 2009 Nov 4;85(19e20):693e699.

Fernandez-Montequín JI, Betancourt BY, Leyva-Gonzalez G, et al. Intralesional administration of epidermal growth factor-based formulation (Heberprot-P) in chronic diabetic foot ulcer: treatment up to complete wound closure. Int Wound J. 2009 Feb;6(1):67e72.

Berlanga-Acosta J. Diabetic lower extremity wounds: the rationale for growth factors based infiltration treatment. Int Wound J. 2011 Dec;8(6):612e620.

Yamamoto M, Hokugo A, Takahashi Y, Nakano T, Hiraoka M, Tabata Y. Combination of BMP-2-releasing gelatin/b-TCP sponges with autologous bone marrow for bone regeneration of X-ray-irradiated rabbit ulnar defects. Biomaterials. 2015 Jul;56:18e25.

Yang CH. Evaluation of the release rate of bioactive recombinant human epidermal growth factor from crosslinking collagen sponges. J Mater Sci Mater Med. 2008 Mar;19(3):1433e1440.